Filing Details
- Accession Number:
- 0001127602-24-028297
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-02 16:19:31
- Reporting Period:
- 2024-11-27
- Accepted Time:
- 2024-12-02 16:19:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1866132 | Thyme Shannon Klinger | 325 Binney Street Cambridge MA 02142 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-27 | 329 | $0.00 | 18,483 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-11-27 | 2,652 | $0.00 | 21,135 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-29 | 1,418 | $42.79 | 19,717 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2024-11-27 | 329 | $0.00 | 329 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-11-27 | 2,652 | $0.00 | 2,652 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,959 | No | 4 | M | Direct | ||
| 2,653 | No | 4 | M | Direct |
Footnotes
- Restricted stock units convert into common stock on a one-for-one basis.
- Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentiveplans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.
Billionaire Hedge Funds
